| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,895 |
4,169 |
$1.25M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,089 |
844 |
$335K |
| 80053 |
Comprehensive metabolic panel |
2,859 |
2,394 |
$247K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
967 |
883 |
$167K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
384 |
270 |
$122K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
613 |
553 |
$82K |
| 71046 |
Radiologic examination, chest; 2 views |
385 |
341 |
$60K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
397 |
323 |
$50K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
417 |
348 |
$34K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
357 |
287 |
$33K |
| 84443 |
Thyroid stimulating hormone (TSH) |
517 |
469 |
$32K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
555 |
467 |
$30K |
| 86140 |
|
386 |
332 |
$24K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,115 |
1,766 |
$24K |
| A0425 |
Ground mileage, per statute mile |
594 |
441 |
$23K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
310 |
266 |
$19K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
113 |
78 |
$18K |
| 84484 |
|
447 |
290 |
$14K |
| 80061 |
Lipid panel |
583 |
536 |
$13K |
| 85027 |
|
606 |
533 |
$13K |
| 71045 |
Radiologic examination, chest; single view |
153 |
122 |
$12K |
| 83690 |
|
236 |
201 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
2,036 |
1,702 |
$9K |
| 85610 |
|
310 |
251 |
$9K |
| 83605 |
|
191 |
164 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
183 |
146 |
$8K |
| 70450 |
Computed tomography, head or brain; without contrast material |
12 |
12 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
57 |
48 |
$7K |
| 80076 |
|
80 |
67 |
$6K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
30 |
25 |
$5K |
| 85730 |
|
176 |
153 |
$5K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
91 |
76 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
339 |
316 |
$5K |
| 94761 |
|
53 |
45 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
36 |
32 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
40 |
37 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
33 |
31 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
486 |
325 |
$3K |
| 84439 |
|
54 |
53 |
$2K |
| 85652 |
|
63 |
56 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
41 |
41 |
$2K |
| 81001 |
|
523 |
471 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16 |
13 |
$752.98 |
| 83735 |
|
47 |
39 |
$674.15 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
76 |
53 |
$428.89 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
28 |
26 |
$398.69 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12 |
12 |
$335.18 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
23 |
12 |
$248.64 |
| 82570 |
|
14 |
13 |
$204.30 |
| 81003 |
|
76 |
68 |
$201.52 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
18 |
16 |
$74.88 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
18 |
16 |
$36.17 |